Mechanisms of fibrinogen-induced microvascular dysfunction during cardiovascular disease

Acta Physiologica

Volumn 198, Issue 1, 2010, Pages 1-13

  Lominadze, D ^a   Dean, W L ^a   Tyagi, S C ^a   Roberts, A M ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Arteriolar constriction; Endothelial cell layer permeability; Endothelin 1; Erythrocyte aggregation; Tight junction proteins; Weibel Palade body exocytosis

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; F ACTIN; FIBRINOGEN; INTERCELLULAR ADHESION MOLECULE 1; MEMBRANE RECEPTOR; METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; VERY LATE ACTIVATION ANTIGEN 5;

BLOOD FLOW; BLOOD RHEOLOGY; BLOOD VESSEL REACTIVITY; BLOOD VISCOSITY; CARDIOVASCULAR DISEASE; CELL ACTIVATION; CELL MEMBRANE PERMEABILITY; DIABETES MELLITUS; ENDOTHELIAL DYSFUNCTION; ERYTHROCYTE AGGREGATION; FIBRINOGEN BLOOD LEVEL; HUMAN; HYPERTENSION; INFLAMMATION; MICROANGIOPATHY; MICROCIRCULATION; NONHUMAN; PATHOGENESIS; PERIPHERAL CIRCULATION; PLASMA VISCOSITY; PRIORITY JOURNAL; REVIEW; SHEAR STRESS; SIGNAL TRANSDUCTION; STROKE; THROMBOGENESIS; TIGHT JUNCTION; VASCULAR ENDOTHELIUM; VASCULAR RESISTANCE;

ANIMALS; BLOOD VISCOSITY; CARDIOVASCULAR DISEASES; ERYTHROCYTE AGGREGATION; FIBRINOGEN; HUMANS; MICROCIRCULATION;

EID: 71649101901     PISSN: 17481708     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1748-1716.2009.02037.x     Document Type: Review

References (170)

1. Altieri, D., Duperray, A., Plescia, J., Thornton, G. Languino, L. 1995. Structural recognition of a novel fibrinogen gamma chain sequence (117-133) by intercellular adhesion molecule-1 mediates leukocyte-endothelium interaction. J Biol Chem 270, 696 699.
2. Anderson, R., Saldeen, K. Saldeen, T. 1983. A fibrin(ogen) derived pentapeptide induces vasodilation, prostacyclin release and an increase in cyclic AMP. Thromb Res 30, 213 218.
3. Aoudjit, F., Potworowski, E.F. St-Pierre, Y. 1998. Bi-directional induction of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 during T lymphoma/endothelial cell contact: implication of ICAM-1. J Immunol 160, 2967 2973.
4. Areekul, S. 1986. Plasmodium coatneyi: alterations of transcapillary escape rate and capillary permeability to fibrinogen in rhesus monkeys. Exp Parasitol 61, 304 310. (Pubitemid 16069842)
5. Barczak-Osinska, J., Buczko, W. Wisniewski, K. 1983. The effect of products of degradation of fibrinogen A and B on the arterial blood pressure in the rat. Pol J Pharmacol Pharm 35, 279 283.
6. Barnes, G. Frieden, E. 1984. Ceruloplasmin receptors of erythrocytes. Biochem Biophys Res Commun 125, 157 162.
7. Bas, M., Kirchhartz, N., Hochfeld, J., Tüllmann, C., Kumpf, S., Suvorava, T., Oppermann, M., Hafner, D., Bier, H., Hoffmann, T.K., Balz, V. Kojda, G. 2008. Potential role of vasomotor effects of fibrinogen in bradykinin-induced angioedema. J Allergy Clin Immunol 121, 969 975.
8. Becker, B., Heindl, B., Kupatt, C. Zahler, S. 2000. Endothelial function and hemostasis. Z Kardiol 89, 160 167.
9. Bennett, J. 2001. Platelet-fibrinogen interactions. Ann N Y Acad Sci 936, 340 354.
10. Bezie, Y., Lacolley, P., Laurent, S. Gabella, G. 1998. Connection of smooth muscle cells to elastic lamellae in aorta of spontaneously hypertensive rats. Hypertension 32, 166 169.
11. Bloch, E. 1956. Microscopic observations of the circulating blood in the bulbar conjunctiva in man in health and disease. Ergeb Anat Entwicklungsgesch 35, 1 98.
12. Bohlen, H.G. 1979. Arteriolar closure mediated by hyperresponsiveness to norepinephrine in hypertensive rats. Am J Physiol 236, H157 H164.
13. Bohlen, H. 1989. The microcirculation in hypertension. J Hypertens 7, S117 S124.
14. Boutcher, P., Gaffney, P., Raut, S., O'Regan, R. McLoughlin, P. 1996. Effects of early plasmin digests of fibrinogen on isometric tension development in isolated rings of rat pulmonary artery. Thromb Res 81, 231 239. (Pubitemid 26078548)
15. Buchsbaum, R., Connolly, B. Feig, L. 2002. Interaction of Rac exchange factors Tiam1 and Ras-GRF1 with a scaffold for the p38 mitogen-activated protein kinase cascade. Mol Cell Biol 22, 4073 4085.
16. Buemi, M., Allegra, A., Aloisi, C., Corica, F., Alonci, A., Ruello, A., Gaetano, M. Nicola, F. 1997. Cold pressor test raises serum concentrations of ICAM-1, VCAM-1, and E-selectin in normotensive and hypertensive patients. Hypertension 30, 845 847.
17. Burnstock, G. Ralevic, V. 1994. New insights into the local regulation of blood flow by perivascular nerves and endothelium. Br J Plast Surg 47, 527 543.
18. Cabel, M., Meiselman, H., Popel, A. Johnson, P. 1997. Contribution of red blood cell aggregation to venous vascular resistance in skeletal muscle. Am J Physiol Heart Circ Physiol 272, H1020 H1032.
19. Chabanel, A. Chien, S. 1990. Blood viscosity as a factor in human hypertension. In: H. Laragh B.M. Brenner (eds) Hypertension Pathophysiology, Diagnosis and Management, pp. 329 337. Raven Press, New York.
20. Chabanel, A., Schachter, D. Chien, S. 1987. Increased rigidity of red cell membrane in young spontaneously hypertensive rats. Hypertension 10, 603 607.
21. Chae, C., Lee, R., Rifai, N. Ridker, P. 2001. Blood pressure and inflammation in apparently healthy men. Hypertension 38, 399 403.
22. Chen, C. Schachter, D. 1993. Elevation of plasma immunoglobulin A in the spontaneously hypertensive rat. Hypertension 21, 731 738.
23. Chien, S. 1986. Blood rheology in myocardial infarction and hypertension. Biorheology 23, 633 653.
24. Chien, S. Jan, K.-M. 1973. Ultrastructural basis of the mechanism of rouleaux formation. Microvasc Res 5, 155 166.
25. Chien, S., Usami, S., Dellenback, R.J., Gregersen, M.I., Nanninga, L.B. Guest, M.M. 1967. Blood viscosity: influence of erythrocyte aggregation. Science 157, 829 831.
26. Cohen, Z., Gonzales, R., Davis-Gorman, G., Copeland, J. McDonagh, P. 2002. Thrombin activity and platelet microparticle formation are increased in type 2 diabetic platelets: a potential correlation with caspase activation. Thromb Res 107, 217 221.
27. Collen, D., Tytgat, G., Claeys, H. Piessens, R. 1972. Metabolism and distribution of fibrinogen. I. Fibrinogen turnover in physiological conditions in humans. Br J Haematol 22, 681 700.
28. D'Angelo, G., Mogford, J.E., Davis, G.E., Davis, M.J. Meininger, G.A. 1997. Integrin-mediated reduction in vascular smooth muscle [Ca2 + ]i induced by RGD-containing peptide. Am J Physiol Heart Circ Physiol 272, H2065 H2070.
29. D'Erasmo, E., Acca, M., Celi, F., Medici, F., Palmerini, T. Pisani, D. 1993. Plasma fibrinogen and platelet count in stroke. J Med 24, 185 191.
30. D'Souza, S., Byers-Ward, V., Gardiner, E., Wang, H. Sung, S.-S. 1996. Identification of an active sequence within the first immunoglobulin domain of intercellular cell adhesion molecule-1 (ICAM-1) that interacts with fibrinogen. J Biol Chem 271, 24270 24277.
31. Dalekos, G., Elisaf, M., Papagalanis, N., Tzallas, C. Siamopoulos, K. 1996. Elevated interleukin-1 beta in the circulation of patients with essential hypertension before any drug therapy: a pilot study. Eur J Clin Invest 26, 936 939.
32. Danesh, J., Lewington, S., Thompson, S.G., Lowe, G.D., Collins, R., Kostis, J.B., Wilson, A.C., Folsom, A.R., Wu, K., Benderly, M. et al. 2005. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA 294, 1799 1809.
33. Davies, P., Zilberberg, J. Helmke, B. 2003. Spatial microstimuli in endothelial mechanosignaling. Circ Res 92, 359 370.
34. De Maat, M. 2001. Effects of diet, drugs, and genes on plasma fibrinogen levels. Ann N Y Acad Sci 2001, 936.
35. Deng, L.-Y., Li, J.S. Schiffrin, E.L. 1995. Endothelin receptor subtypes in resistance arteries from humans and rats. Cardiovasc Res 29, 532 535.
36. DeSouza, C., Dengel, D., Maeko, R., Cox, K. Seals, D. 1997. Elevated levels of circulating cell adhesion molecules in uncomplicated essential hypertension. Am J Hypertens 10, 1335 1341. (Pubitemid 28078736)
37. Dintenfass, L. 1978. Blood-pressure and blood viscosity in coronary heart-disease. Lancet 2, 993 994.
38. Ernst, E. Resch, K. 1993. Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med 118, 956 963. (Pubitemid 23164134)
39. Etienne, S., Adamson, P., Greenwood, J., Strosberg, A., Cazaubon, S. Couraud, P. 1998. ICAM-1 signaling pathways associated with Rho activation in microvascular brain endothelial cells. J Immunol 161, 5755 5761.
40. Evans, E. Needham, D. 1988. Attraction between lipid bilayer membranes in concentrated solutions of nonadsorbing polymers: comparison of mean-field theory with measurements of adhesion energy. Macromolecules 21, 1822 1831.
41. Folkow, B. 1978. The fourth Volhard lecture: cardiovascular structural adaptation; its role in the initiation and maintenance of primary hypertension. Clin Sci Mol Med 55, 3s 22s.
42. Förster, C. 2008. Tight junctions and the modulation of barrier function in disease. Histochem Cell Biol 130, 55 70.
43. Fukushige, H., Doi, Y., Kudo, H., Kayashima, K., Kiynaga, H., Nagata, T., Itoh, H. Fujimoto, S. 2000. Synthesis and receptor sites of endothelin-1 in the rat liver vasculature. Anat Rec 259, 437 445.
44. Gaffney, P. 2001. Fibrin degradation products: a review of structures found in vitro and in vivo. Ann N Y Acad Sci 936, 594 610.
45. Game, L., Voegel, J.-C., Schaaf, P. Stoltz, J. 1996. Do physiological concentrations of IgG induce a direct aggregation of red blood cells: comparison with fibrinogen. Biochim Biophys Acta 1291, 138 142.
46. Garcia, J., Wang, P., Schaphorst, K., Becker, P., Borbiev, T., Liu, F., Birukova, A., Jacobs, K., Bogatcheva, N. Verin, A. 2002. Critical involvement of p38 MAP kinase in pertussis toxin-induced cytoskeletal reorganization and lung permeability. FASEB J 16, 1064 1076.
47. Ge, M., Ryan, T.J., Lum, H. Malik, A.B. 1991. Fibrinogen degradation product fragment D increases endothelial monolayer permeability. Am J Physiol Lung Cell Mol Physiol 261, L283 L289.
48. Ge, M., Tang, G., Ryan, T. Malik, A. 1992. Fibrinogen degradation product fragment D induces endothelial cell detachment by activation of cell-mediated fibrinolysis. J Clin Invest 90, 2508 2516.
49. Giancotti, F. Ruoslahti, E. 1999. Integrin signaling. Science 285, 1028 1032.
50. Gladner, J., Murtaugh, P., Folk, J. Laki, K. 1963. Nature of peptides released by thrombin. Ann N Y Acad Sci 104, 47 52.
51. Guo, M., Daines, D., Tang, J., Shen, Q., Perrin, R.M., Takada, Y., Yuan, S.Y. Wu, M.H. 2009. Fibrinogen-{gamma} C-terminal fragments induce endothelial barrier dysfunction and microvascular leak via integrin-mediated and RhoA-dependent mechanism. Arterioscler Thromb Vasc Biol 29, 394 400.
52. Gustafsson, L., Appelgren, L. Myrvold, H.E. 1981a. Blood flow and in vivo apparent viscosity in working and non-working skeletal muscle of the dog after high and low molecular weight dextran. Circ Res 48, 465 469.
53. Gustafsson, L., Appelgren, L. Myrvold, H.E. 1981b. Effects of increased plasma viscosity and red blood cell aggregation on blood viscosity in vivo. Am J Physiol Heart Circ Physiol 241, H513 H518.
54. Hacioglu, G., Yalcin, O., Bor-Kucukatay, M., Ozkaya, G. Baskurt, O. 2002. Red blood cell rheological properties in various rat hypertension models. Clin Hemorheol Microcirc 26, 27 32.
55. Hamsten, A., Iselius, L., de Faire, U. Blomback, M. 1987. Genetic and cultural inheritance of plasma fibrinogen concentration. Lancet 2, 988 991.
56. Harper, S. Bohlen, H. 1984. Microvascular adaptation in the cerebral cortex of adult spontaneously hypertensive rats. Hypertension 6, 408 419.
57. Hermand, P., Gane, P., Huet, M., Jallu, V., Kaplan, C., Sonneborn, H.H., Cartron, J.P. Bailly, P. 2003. Red cell ICAM-4 is a novel ligand for platelet-activated alpha IIbbeta 3 integrin. J Biol Chem 278, 4892 4898.
58. Hicks, R., Golledge, J., Mir-Hasseine, R. Powell, J. 1996. Vasoactive effects of fibrinogen on saphenous vein. Nature 379, 818 820.
59. Humphries, S. 1995. Genetic regulation of fibrinogen. Eur Heart J 16, 16 20.
60. Humphries, S., Cook, M., Dubowitz, M., Stirling, Y. Meade, T.W. 1987. Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentrations. Lancet 1, 1452 1455.
61. Hynes, R. 1999. Cell adhesion: old and new questions. Trends Cell Biol 9, M33 M37.
62. Iida, M., Yamamoto, M., Yamazaki, M., Sawaguchi, M., Honjo, H., Kodama, I. Kamiya, K. 2008. Association of aortic valve sclerosis with thrombin generation in hypertensive patients. J Hum Hypertens 22, 781 787.
63. Inoue, A., Yanagisawa, M., Kimura, S., Kasuya, Y., Miyauchi, T., Goto, K. Masaki, T. 1989. Human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA 86, 2863 2867.
64. Intengan, H. Schiffrin, E. 2000. Structure and mechanical properties of resistance arteries in hypertension; role of adhesion molecules and extracellular matrix determinants. Hypertension 36, 312 318.
65. Intengan, H., Thibault, G., Li, J.-S. Schiffrin, E. 1999. Resistance artery mechanics, structure, and extracellular components in spontaneously hypertensive rats: effects of angiotensin receptor antagonism and converting enzyme inhibition. Circulation 100, 2267 2275.
66. Ishizuka, T., Takamizawa-Matsumoto, M., Suzuki, K. Kurita, A. 1999. Endothelin-1 enhances vascular cell adhesion molecule-1 expression in tumor necrosis factor a-stimulated vascular endothelial cells. Eur J Pharmacol 369, 237 245.
67. John, T., Vogel, S., Tiruppathi, C., Malik, A. Minshall, R. 2003. Quantitative analysis of albumin uptake and transport in the rat microvessel endothelial monolayer. Am J Physiol Lung Cell Mol Physiol 284, L187 L196.
68. Johnson, A., Tahamont, M.V. Malik, A.B. 1983. Thrombin-induced lung vascular injury. Roles of fibrinogen and fibrinolysis. Am Rev Respir Dis 128, 38 44.
69. Johnson, A., Garcia-Szabo, R., Kaplan, J. Malik, A. 1985. Fibrin degradation products increase lung transvascular fluid filtration after thrombin-induced pulmonary microembolism. Thromb Res 37, 543 554.
70. Juan, S., Chen, J., Chen, C., Lin, H., Cheng, C., Liu, J., Hsieh, M., Chen, Y., Chao, H., Chen, T., Chan, P. Cheng, T. 2004. 17{beta}-Estradiol inhibits cyclic strain-induced endothelin-1 gene expression within vascular endothelial cells. Am J Physiol Heart Circ Physiol 287, H1254 H1261.
71. Kannan, H., Tanaka, Y., Kunitake, T., Ueta, Y., Hayashida, Y. Yamashita, H. 1996. Activation of sympathetic outflow by recombinant human interleukin-1 beta in conscious rats. Am J Physiol 270, R479 R485.
72. Kano, Y., Katoh, K., Masuda, M. Fujiwara, K. 1996. Macromolecular composition of stress fiber-plasma membrane attachment sites in endothelial cells in situ. Circ Res 79, 1000 1006.
73. Kern, D., Saldeen, K., Saldeen, T. Malik, A. 1986. Pulmonary vascular effects of a fibrin(ogen)-derived vasoactive peptide. Thromb Res 42, 783 788.
74. King, J., Srivastava, K., Stefano, G., Bilfinger, T., Bahou, W. Magazine, H. 1997. Human monocyte adhesion is modulated by endothelin B receptor-coupled nitric oxide release. J Immunol 158, 880 886. (Pubitemid 127492667)
75. Knisely, M. 1965. Intravascular erythrocyte aggregation (blood sludge). In: E. Renkin C. Michel (eds) Handbook of Physiology; A Critical, Comprehensive Presentation of Physiological Knowledge and Concepts, pp. 2249 2292. American Physiological Society, Bethesda, MD.
76. Koenig, W., Sund, M., Ernst, E., Matrai, A., Keil, U. Rosenthal, J. 1989. Is increased plasma viscosity a risk factor for high blood pressure? Angiology 40, 153 163.
77. Krobot, K., Hense, H., Cremer, P., Eberle, E. Keil, U. 1992. Determinants of plasma fibrinogen: relation to body weight, waist-to-hip ratio, smoking, alcohol, age, and sex. Results from the second MONICA Augsburg survey 1989-1990. Arterioscler Thromb 12, 780 788.
78. Laki, K. 1951. The action of thrombin on fibrinogen. Science 114, 435 436.
79. Lampugnani, M., Resnati, M., Dejana, E. Marchisio, P. 1991. The role of integrins in the maintenance of endothelial monolayer integrity. J Cell Biol 112, 479 490.
80. Landin, K., Tengborn, L. Smith, U. 1990. Elevated fibrinogen and plasminogen activator inhibitor (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease. J Intern Med 227, 273 278.
81. Languino, L., Plescia, J., Duperrray, A., Brian, A., Plow, E., Geltosky, J. Alteri, D. 1993. Fibrinogen mediates leukocyte adhesion to vascular endothelium through an ICAM-1-dependent pathway. Cell 73, 1423 1434.
82. Ledesma, M., Da Silva, J., Crassaerts, K., Delacourte, A., De Strooper, B. Dotti, C. 2000. Brain plasmin enhances APP alpha-cleavage and Abeta degradation and is reduced in Alzheimer's disease brains. EMBO Rep 1, 530 535.
83. Letcher, R., Chien, S., Pickering, T., Sealey, J. Laragh, J. 1981. Direct relationship between blood pressure and blood viscosity in normal and hypertensive subjects. Role of fibrinogen and concentration. Am J Med 70, 1195 1202.
84. Letcher, R., Chien, S., Pickering, T. Laragh, J. 1983. Elevated blood viscosity in patients with borderline essential hypertension. Hypertension 5, 757 762.
85. Li, F. Joshua, I. 1993. Decreased arteriolar endothelium-derived relaxing factor production during the development of genetic hypertension. Clin Exp Hypertens 15, 511 526.
86. Lim, L., Manser, E., Leung, T. Hall, C. 1996. Regulation of phosphorylation pathways by p21 GTPases. The p21 Ras-related Rho subfamily and its role in phosphorylation signaling pathways. Eur J Biochem 242, 171 185.
87. Lip, G. 1995. Fibrinogen and cardiovascular disorders. Q J Med 88, 155 165.
88. Lip, G. Beevers, D. 2007. Abnormalities of rheology and coagulation in hypertension. J Hum Hypertens 8, 693 702.
89. Lominadze, D. Dean, W. 2002. Involvement of fibrinogen specific binding in erythrocyte aggregation. Clin Exp Hypertens 517, 41 44.
90. Lominadze, D., Joshua, I. Schuschke, D. 1998. Increased erythrocyte aggregation in spontaneously hypertensive rats. Am J Hypertens 11, 784 789. (Pubitemid 28351010)
91. Lominadze, D., Schuschke, D., Joshua, I. Dean, W. 2002. Increased ability of erythrocytes to aggregate in spontaneously hypertensive rats. Clin Exp Hypertens 24, 397 406.
92. Lominadze, D., Tsakadze, N., Sen, U., Falcone, J. D'Souza, S. 2005. Fibrinogen-and fragment D-induced vascular constriction. Am J Physiol 288, H1257 H1264.
93. London, M. 1997. The role of blood rheology in regulating blood pressure. Clin Hemorheol Microcirc 17, 93 106.
94. Lowe, G. Rumley, A. 2001. Fibrinogen and its degradation products as thrombotic risk factors. Ann N Y Acad Sci 936, 560 565.
95. Lowe, G., Lee, A., Rumley, A., Price, J. Fowkes, F. 1997. Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study. Br J Haematol 96, 168 173.
96. Lund-Johansen, P. 1983. The hemodynamics of hypertension. In: J. Robertson (ed Handbook of Hypertension, pp. 151 173. Elsevier, Amsterdam.
97. Luscinskas, F. Lawler, J. 1994. Integrins as dynamic regulators of vascular function. FASEB J 8, 929 938.
98. Ly, D., Zazzali, K. Corbett, S. 2003. De novo expression of the integrin alpha5beta1 regulates alphavbeta3-mediated adhesion and migration on fibrinogen. J Biol Chem 278, 21878 21885.
99. Manneville, J., Etienne-Manneville, S., Skehel, P., Carter, T., Ogden, D. Ferenczi, M. 2003. Interaction of the actin cytoskeleton with microtubules regulates secretory organelle movement near the plasma membrane in human endothelial cells. J Cell Sci 116, 3927 3938.
100. Manwaring, D. Curreri, P. 1981. Cellular mediation of respiratory distress syndrome induced by fragment D. Ann Chir Gynaecol 70, 304 307.
101. Marsault, R., Vigne, P., Breittmayer, J. Frelin, C. 1991. Kinetics of vasoconstrictor action of endothelins. Am J Physiol 261, C987 C993.
102. Martinez, J., Holburn, R., Shapiro, S. Erslev, A. 1974. Fibrinogen Philadelphia: a hereditary hypodysfibrinogenemia characterized by fibrinogen hypercatabolism. J Clin Invest 53, 600 611.
103. Martinez-Lemus, L.A., Crow, T., Davis, M.J. Meininger, G.A. 2005. {alpha}v{beta}3-and {alpha}5{beta}1-integrin blockade inhibits myogenic constriction of skeletal muscle resistance arterioles. Am J Physiol Heart Circ Physiol 289, H322 H329.
104. Maspers, M., Björnberg, J. Mellander, S. 1990. Relation between capillary pressure and vascular tone over the range from maximum dilatation to maximum constriction in cat skeletal muscle. Acta Physiol Scand 140, 73 83.
105. Mchedlishvili, G., Beritashvili, N., Lominadze, D. Tsinamdzvrishvili, B. 1993. Technique for direct and quantitative evaluation of erythrocyte aggregability in blood samples. Biorheology 30, 153 161.
106. Mehta, D. Malik, A. 2006. Signaling mechanisms regulating endothelial permeability. Physiol Rev 86, 279 367.
107. Mehta, J., Wargovich, T., Nichols, W., Saldeen, K., Wallin, R. Saldeen, T. 1985. Peptide 6A, a fibrin(ogen) degradation product, increases coronary blood flow. Am J Physiol 249, H457 H462.
108. Meininger, G., Harris, P., Joshua, I., Miller, F. Wiegman, D. 1981. Microvascular pressures in skeletal muscle of one-kidney one-clip renovascular hypertensive rats. Microcirculation 1, 237 254.
109. Mogford, J., Davis, G., Platts, S. Meininger, G. 1996. Vascular smooth muscle alpha v beta 3 integrin mediates arteriolar vasodilation in response to RGD peptides. Circ Res 79, 821 826. (Pubitemid 26317830)
110. 1 integrin causes sustained endothelial-dependent vasoconstrictionto rat skeletal muscle arterioles. J Clin Invest 100, 1647 1653.
111. Morey, A., Razandi, M., Pedram, A., Hu, R., Prins, B. Levin, E. 1998. Oestrogen and progesterone inhibit the stimulated production of endothelin-1. Biochem J 15, 1097 1105.
112. Nakamura, S., Naruse, M., Naruse, K., Demura, H. Uemura, H. 1990. Immunocytochemical localization of endothelin in cultured bovine endothelial cells. Histochemistry 94, 475 477.
113. Nakamura, A., Kohsaka, T. Johns, E. 1996. Neuro-regulation of interleukin-6 gene expression in the spontaneously hypertensive rat kidney. J Hypertens 14, 839 845.
114. Nichols, W., Mehta, J., Wargovich, T., Saldeen, K., Wallin, R. Saldeen, T. 1985. Fibrin(ogen)-derived peptide B beta 30-43 increases coronary blood flow in the anesthetized dog. Thromb Res 39, 223 229.
115. Pankow, J., Folsom, A., Province, M., Rao, D., Williams, R., Eckfeldt, J. Sellers, T. 1998. Segregation analysis of plasminogen activator inhibitor-1 and fibrinogen levels in the NHLBI family heart study. Arterioscler Thromb Vasc Biol 18, 1559 1567. (Pubitemid 28465407)
116. Patibandla, P.K., Tyagi, N., Dean, W.L., Tyagi, S.C., Roberts, A.M. Lominadze, D. 2009. Fibrinogen induces alterations of endothelial cell tight junction proteins. J Cell Physiol 221, 195 203.
117. Paul, J., Strickland, S. Melchor, J.P. 2007. Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease. J Exp Med 204, 1999 2008.
118. Pedersen, K., Rigby, P. Goldie, R. 1991. Quantitative assessment of increased airway microvascular permeability to 125I-labelled plasma fibrinogen induced by platelet activating factor and bradykinin. Br J Pharmacol 104, 128 132.
119. Platts, S.H., Mogford, J.E., Davis, M.J. Meininger, G.A. 1998. Role of K+ channels in arteriolar vasodilation mediated by integrin interaction with RGD-containing peptide. Am J Physiol Heart Circ Physiol 275, H1449 H1454.
120. Plow, E., Haas, T., Zhang, L., Loftus, J. Smith, J. 2000. Ligand binding to integrins. J Biol Chem 275, 21785 21788.
121. Pluskota, E. D'Souza, S. 2000. Fibrinogen interactions with ICAM-1 (CD54) regulate endothelial cell survival. Eur J Biochem 267, 4693 4704.
122. Porteri, E., Rizzoni, D., Piccoli, A., Castellano, M., Bettoni, G., Muiesan, M., Pasini, G., Guelfi, D., Zulli, R. Rosei, E. 1998. Effects of hypotensive and non-hypotensive doses of manidipine on structure, responses to endothelin-1 and ICAM-1 production in mesenteric small resistance arteries of spontaneously hypertensive rats. Blood Press 7, 324 330.
123. Predescu, D. Palade, G. 1993. Plasmalemmal vesicles represent the large pore system of continuous microvascular endothelium. Am J Physiol 265, H725 H733.
124. Putnam, F.W. 1984. The Plasma Proteins: Structure, Function, and Genetic Control. Academic Press, New York.
125. Pytela, R., Pierschbacher, M.D. Ruoslahti, E. 1985. A 125/115-kDa cell surface receptor specific for vitronectin interacts with the arginine-glycine-aspartic acid adhesion sequence derived from fibronectin. Proc Natl Acad Sci USA 82, 5766 5770.
126. Qiao, R., Yan, W., Lum, H. Malik, A. 1995. Arg-Gly-Asp peptide increases endothelial hydraulic conductivity: comparison with thrombin response. Am J Physiol Cell Physiol 269, C110 C117.
127. Qizilbash, N. 1995. Fibrinogen and cerebrovascular disease. Eur Heart J 16, 42 46.
128. Rampling, M., Meiselman, H., Neu, B. Baskurt, O. 2004. Influence of cell-specific factors on red blood cell aggregation. Biorheology 41, 91 112.
129. Roberts, A., Slaaf, D. Joshua, I. 1998. Potentiation of pulmonary arteriolar vasoconstriction to endothelin-1 by inhibition of nitric oxide synthesis in the intact lung. Microcirculation 5, 289 298.
130. Ross, R. 1999. Atherosclerosis-an inflammatory disease. N Engl J Med 340, 115 126.
131. Ruggeri, Z. 1993. Mechanisms of shear-induced platelet-adhesion and aggregation. Thromb Haemost 70, 119 123.
132. Russell, F., Skepper, J. Davenport, A. 1998a. Endothelin peptide and converting enzymes in human endothelium. J Cardiovasc Pharmacol 31, S19 S21.
133. Russell, F., Skepper, J. Davenport, A. 1998b. Human endothelial cell storage granules: a novel intracellular site for isoforms of the endothelin-converting enzyme. Circ Res 83, 314 321.
134. Saenko, E. Yaropolov, A. 1990. Studies on receptor interaction of ceruloplasmin with human red blood cells. Biochem Int 20, 215 225.
135. Saldeen, K., Nichols, W., Lawson, D., Andersson, R., Saldeen, T. Mehta, J. 1991. Fibrin(ogen) degradation product peptide 6A increases femoral artery blood flow in dogs. Acta Physiol Scand 142, 339 344.
136. Savoia, C. Schiffrin, E.L. 2006. Inflammation in hypertension. Curr Opin Nephrol Hypertens 15, 152 158.
137. Schlaepfer, D. Hunter, T. 1998. Integrin signalling and tyrosine phosphorylation: just the FAKs? Trends Cell Biol 8, 151 157.
138. Schmitz-Spanke, S. Schipke, J. 2000. Potential role of endothelin-1 and endothelin antagonists in cardiovascular diseases. Basic Res Cardiol 95, 290 298.
139. Sen, U., Tyagi, N., Patibandla, P.K., Dean, W.L., Tyagi, S.C., Roberts, A.M. Lominadze, D. 2009. Fibrinogen-induced endothelin-1 production from endothelial cells. Am J Physiol Cell Physiol 296, C840 C847.
140. Shyy, J.-J. Chien, S. 2002. Role of integrins in endothelial mechanosensing of shear stress. Circ Res 91, 769 775.
141. Smith, E. 1994. Fibrin deposition and fibrin degradation products in atherosclerotic plaques. Thromb Res 75, 329 335.
142. Smith, J.W., Ruggeri, Z.M., Kunicki, T.J. Cheresh, D.A. 1990. Interaction of integrins alpha v beta 3 and glycoprotein IIb-IIIa with fibrinogen. Differential peptide recognition accounts for distinct binding sites. J Biol Chem 265, 12267 12271.
143. Srivastava, K. Magazine, H. 1998. Thrombin receptor activation inhibits monocyte spreading by induction of ET(B) receptor-coupled nitric oxide release. J Immunol 161, 5039 5044.
144. 5beta1 on endothelial cells. J Biol Chem 272, 5360 5366.
145. Suehiro, K., Mizuguchi, J., Nishiyama, K., Iwanaga, S., Farrell, D.H. Ohtaki, S. 2000. Fibrinogen binds to integrin alpha(5)beta(1) via the carboxyl-terminal RGD site of the Aalpha-chain. J Biochem 128, 705 710.
146. Tikkanen, I., Uhlenius, N., Tikkanen, T., Miettinen, A., Tornroth, T., Fyhrquist, F. Holthofer, H. 1995. Increased renal expression of cytokines and growth factors induced by DOCA-NaCl treatment in Heymann nephritis. Nephrol Dial Transplant 10, 2192 2198.
147. Tyagi, N., Roberts, A., Dean, W., Tyagi, S. Lominadze, D. 2008. Fibrinogen induces endothelial cell permeability. Mol Cell Biochem 307, 13 22.
148. Urbich, C., Walter, D., Zeiher, A. Dimmler, S. 2000. Laminar shear stress upregulates integrin expression: role in endothelial cell adhesion and apoptosis. Circ Res 87, 683 689.
149. Van Aelst, L. D'Souza-Schorey, C. 1997. Rho GTPases and signaling networks. Genes Dev 11, 2295 2322.
150. Vasse, M., Paysant, J., Soria, J., Collet, J., Vannier, J. Soria, C. 1996. Regulation of fibrinogen biosynthesis by cytokines, consequences on the vascular risk. Haemostasis 26, 331 339.
151. Vicaut, E. 1995. Opposite effects of red blood cell aggregation on resistance to blood flow. J Cardiovasc Surg 36, 361 368.
152. Vicaut, E., Hou, X., Decuypère, L., Taccoen, A. Duvelleroy, M. 1994. Red blood cell aggregation and microcirculation in rat cremaster muscle. Int J Microcirc 14, 14 21.
153. Wang, Q. Doerschuk, C. 2001. The p38 mitogen-activated protein kinase mediates cytoskeletal remodeling in pulmonary microvascular endothelial cells upon intracellular adhesion molecule-1 ligation. J Immunol 166, 6877 6884.
154. Wang, Q., Yerukhimovich, M., Gaarde, W., Popoff, I. Doerschuk, C. 2005. MKK3 and-6-dependent activation of p38 MAP kinase is required for cytoskeletal changes in pulmonary microvascular endothelial cells induced by ICAM-1 ligation. Am J Physiol Lung Cell Mol Physiol 288, L359 L369.
155. Wang, T.J., Gona, P., Larson, M.G., Levy, D., Benjamin, E.J., Tofler, G.H., Jacques, P.F., Meigs, J.B., Rifai, N., Selhub, J., Robins, S.J., Newton-Cheh, C. Vasan, R.S. 2007. Multiple biomarkers and the risk of incident hypertension. Hypertension 49, 432 438.
156. Watts, S.W. 2000. 5-Hydroxytryptamine-induced potentiation of of endothelin-1-and norepinephrine-induced contraction is mitogen-activated protein kinase pathway dependent. Hypertension 35, 244 248.
157. Weis, S. 2008. Vascular permeability in cardiovascular disease and cancer. Curr Opin Hematol 15, 243 249.
158. Weng, X., Cloutier, G., Beaulieu, R. Roederer, G. 1996. Influence of acute-phase proteins on erythrocyte aggregation. Am J Physiol Heart Circ Physiol 271, H2346 H2352.
159. Wiegman, D.L., Joshua, I.G., Morff, R.J., Harris, P.D. Miller, F.N. 1979. Microvascular responses to norepinephrine in renovascular and spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 236, H545 H548.
160. Willoughby, S. Loscanzo, J. 2002. Vascular control of platelet function. In: Gresele, P., Page, CP., Fuster, V., Vermylen, J. (ed Platelets; In Thrombotic and Non-Thrombotic Disorders; Pathophysiology, Pharmacology and Therapeutics, pp. 432 455. Cambridge University Press, New York.
161. Yamakaw, K., Kitamura, K., Nonoguchi, H., Takasu, N., Miller, R. Tomita, K. 2002. G alpha13 induces preproET-1 gene expression via JNK. Hypertens Res 25, 427 432.
162. Yanagisawa, M. 1994. The endothelium system. A new target for the therapeutic intervention. Circulation 89, 1320 1322.
163. Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K. Masaki, T. 1998. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332, 411 415.
164. Yoshimoto, S., Ishizaki, T., Saski, T. Murota, S.-I. 1991. Effect of carbon dioxide and oxygen on endothelin production by cultured porcine cerebral endothelial cells. Stroke 22, 378 383.
165. Yudkin, J., Kumari, M., Humphries, S. Mohamed-Ali, V. 1999. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 148, 209 214.
166. Zacharowski, K., Zacharowski, P., Reingruber, S. Petzelbauer, P. 2006. Fibrin(ogen) and its fragments in the pathophysiology and treatment of myocardial infarction. J Mol Med 84, 1434 1440.
167. Zanetti, A., Conforti, G., Hess, S., Martin-Padura, I., Ghibaudi, E., Preissner, K.T. Dejana, E. 1994. Clustering of vitronectin and RGD peptides on microspheres leads to engagement of integrins on the luminal aspect of endothelial cell membrane. Blood 84, 1116 1123.
168. Zannad, F. Stoltz, J.-F. 1992. Blood rheology in arterial hypertension. J Hypertens 10, S69 S78.
169. Zhao, H., Joshua, I. Porter, J. 2000. Microvascular responses to endothelin in deoxycorticosterone acetate-salt hypertensive rats. Am J Hypertens 13, 819 826.
170. Zilliacus, H. 1951. Intravascular erythrocyte aggregation and the sedimentation reaction in local inflammation in the tissues. Acta Med Scand 140, 149 151.